Search
Search Results
##search.searchResults.foundPlural##
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2531PDF: 1230HTML: 1073 -
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
1154PDF: 609HTML: 385 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4915PDF: 1908HTML: 2192 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2550PDF: 1304HTML: 3618Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 439 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1474PDF: 791HTML: 547 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3194PDF: 1667HTML: 368 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4248PDF: 1041HTML: 19241 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1273PDF: 817HTML: 256 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1536HTML: 655PDF: 885 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3516PDF: 1664HTML: 689 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3302PDF: 1453HTML: 14007jdoe, Dening.MarijuanaFi7.doc: 219jdoe, Dening.MarijuanaFi6.doc: 204jdoe, Dening.MarijuanaFi5.doc: 200jdoe, Dening.MarijuanaFi4.doc: 214jdoe, Dening.MarijuanaFi3.doc: 220jdoe, Dening.MarijuanaFi2.doc: 271jdoe, Dening.MarijuanaFig1.doc: 241 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1530PDF: 1104HTML: 439Suppl. Figure: 204Suppl. Tables: 225 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4151PDF: 1142HTML: 913 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3439PDF: 1290HTML: 8397 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8243PDF: 4453HTML: 7565 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1505PDF: 928HTML: 1965 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1851PDF: 913HTML: 460Fig1: 261Fig.2: 276Fig. 3: 216Fig. 5: 228Fig. 4: 254 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3478PDF: 1529HTML: 4083 -
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2852PDF: 1112HTML: 1960 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1410PDF: 1002HTML: 444 -
SICKLE CELL ANAEMIA AND MALARIA
11797PDF: 7277HTML: 24034Figures Malaria and SCK: 249 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2249PDF: 545HTML: 182 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3463PDF: 2047HTML: 7575 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4687PDF: 1996HTML: 18164 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2242PDF: 1626HTML: 683 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1899PDF: 946HTML: 1021Referring article: 784 -
A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region, Iraq Characterization of COVID-19 in Kurdistan Region, Iraq
1292PDF: 881HTML: 273 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1912PDF: 840HTML: 232 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4390PDF: 1569HTML: 472







